Global Community

Coherus is a promising company that did a bad borrowing and has more than paid the price. Its convertible bondholders created a short hedge and have inflicted massive damage on the company's SP.

In 2024, MAB reported a significant increase in revenue and pre-tax profit, with revenue rising by 11% to around £266m and adjusted pre-tax profit growing by 31% to about £30.5m. The company has set new medium-term targets, including doubling its revenue from 2024 levels, achieving an adjusted pre-tax profit margin above 15%, exceeding 100% cash conversion, and doubling its market share.

When Cost discipline pays off, tariffs subside, and Polestar achieves sustained gross margins above 10%. Expansion of the Polestar 7 lineup from Slovakia accelerates scale.

RIG is either going to survive and boom during the next energy squeeze or it gets bought out. In the first case you get a multi-bagger.

Key Takeaways Accelerating renewables adoption and regulatory pressure threaten long-term demand, margins, and revenue growth for Transocean's offshore drilling business. High debt, aging fleet, and increasing competition constrain financial flexibility and may significantly impact future profitability.

Key Takeaways Regulatory scrutiny, high refund rates, and customer acquisition challenges threaten margins, profitability, and the sustainability of revenue growth. High patient churn and intensifying competition may offset operational efficiencies and limit long-term earnings and margin gains.

Key Takeaways Heavy reliance on emergency authorizations, regulatory uncertainties, and a narrow late-stage pipeline threaten Invivyd's long-term revenue stability and growth prospects. Heightened pricing pressures, high R&D costs, and formidable competition may erode profitability despite strong product demand and innovative advances in antibody engineering.

Key Takeaways High client and revenue concentration plus heavy capital needs expose the company to execution risks, margin pressure, and profitability threats if any major deal falters. Transition away from mining and reliance on favorable energy contracts create vulnerability to market, regulatory, and operational headwinds that could hamper utilization and growth.

Key Takeaways Heavy reliance on DAYBUE and single-indication focus exposes Neuren to significant revenue concentration and regulatory risk. Growing competition, regulatory pressures, and reimbursement scrutiny threaten future margins and the company's long-term growth potential.